Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q1 2023 Earnings

May 15Expected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-13
-8.74
-4.47
-0.21

Details

Expected EPS
-0.56
Actual EPS
-4.76
Surprise EPS
-4.2
Surprise Percent
-750%

Description

⁨Windtree Therapeutics - Warrants (25/03/2026)⁩ (⁦WINT+⁩) has reported earnings of ⁦-4.76⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts